FOLLISTATIN 344

Growth Hormone SecretionResearch Only

Limited human data with only three studies total, one of which documented serious eye complications in bodybuilders using high doses. Animal research shows promise, but the evidence base is too thin to draw meaningful conclusions about safety or efficacy.

Primarily studied by researchers investigating genetic approaches to treating muscular dystrophy and age-related muscle loss, with some anti-doping laboratories developing detection methods.

FDA Status

Research Only

Since Feb 2026

Evidence

Limited data

Studies

3 total, 1 human

What is FOLLISTATIN 344?

This glycoprotein acts as a molecular brake on muscle breakdown signals, making it a target of intense interest in muscle wasting research. Originally discovered for its role in reproductive biology, follistatin 344 represents the full-length version of the protein and has emerged as one of the most potent natural inhibitors of myostatin. Researchers studying muscular dystrophy, age-related sarcopenia, and athletic performance have gravitated toward this peptide for its potential to tip the muscle growth-breakdown balance.

Follistatin 344 works like a molecular sponge, soaking up myostatin and activin proteins before they can reach muscle cells. Myostatin normally acts as a biological speed limit on muscle growth, while activin contributes to muscle breakdown - follistatin essentially removes these brakes by binding to both proteins with extremely high affinity. Think of it as intercepting the 'stop growing' signals before they reach their destination, potentially allowing muscle tissue to develop beyond its normal constraints.

What the Research Shows

Extremely limited research base with just three studies identified - one case report of adverse effects in humans and two animal studies showing modest muscle mass improvements.

Of three studies identified, one human study documented central serous chorioretinopathy associated with high-dose follistatin-344 injections in bodybuilders, while animal studies demonstrated increased lean muscle mass in transgenic pigs (72.95% versus 69.18% control) and established a urine detection method with 0.1 ng/mL limit of detection.